BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Millan MT, Natkunam Y, Clarke-katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM. EPSTEIN-BARR VIRUS INFECTION IS ASSOCIATED WITH ENDOTHELIAL BCL-2 EXPRESSION IN TRANSPLANT LIVER ALLOGRAFTS: . Transplantation 2002;73:465-9. [DOI: 10.1097/00007890-200202150-00023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant. 2004;8:267-272. [PMID: 15176965 DOI: 10.1111/j.1399-3046.2004.00129.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
2 Xiong A, Clarke-katzenberg RH, Valenzuela G, Izumi KM, Millan MT. Epstein-Barr Virus Latent Membrane Protein 1 Activates Nuclear Factor-κB in Human Endothelial Cells and Inhibits Apoptosis. Transplantation 2004;78:41-9. [DOI: 10.1097/01.tp.0000129805.02631.ef] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Weiner C, Weintraub L, Wistinghausen B, Tomaino J, Arnon R, Kerkar N, Miloh T. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease. Pediatr Transplant 2012;16:458-64. [PMID: 22554096 DOI: 10.1111/j.1399-3046.2012.01713.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]